Dr. Shelburne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 NW Expressway St
Oklahoma City, OK 73112
Summary
- Dr. Nicholas Shelburne is a pulmonology specialist based in Nashville, TN. He graduated from Vanderbilt University School of Medicine in 2016. His recent publications focus on pulmonary hypertension, with research articles featured in journals such as CHEST, American Journal of Respiratory and Critical Care Medicine, and Pulmonary Circulation. His work includes topics like the impact of male sex on right ventricular function, prostaglandin therapy in pulmonary arterial hypertension, and methods for optimizing risk stratification in these patients. His publications have been cited by other works, indicating engagement with the scholarly community.
Education & Training
- Vanderbilt University School of MedicineClass of 2016
Certifications & Licensure
- OK State Medical License 2023 - 2025
- TN State Medical License 2020 - 2024
- NC State Medical License 2016 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 1 citationsAssociation of Male Sex With Worse Right Ventricular Function and Survival in Pulmonary Hypertension in the Redefining Pulmonary Hypertension Through Pulmonary Vascula...Nicholas J Shelburne, Hui Nian, Gerald J Beck, Nancy G Casanova, Ankit A Desai
CHEST Pulmonary. 2024-09-01 - Reply to Yasuma.Allison E Norlander, Masako Abney, Jacqueline-Yvonne Cephus, Caroline E Roe, Jonathan M Irish
American Journal of Respiratory and Critical Care Medicine. 2023-12-01 - Prostaglandin ITherapy Promotes Regulatory T Cell Generation in Patients with Pulmonary Arterial Hypertension.Allison E Norlander, Masako Abney, Jacqueline-Yvonne Cephus, Caroline E Roe, Jonathan M Irish
American Journal of Respiratory and Critical Care Medicine. 2023-09-15
Press Mentions
- Bayer Announces Recipients of the Second Annual Pulmonary Hypertension Accelerated AwardsSeptember 10th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: